It was clear early in the pandemic that we’d have to source rapid SARS-CoV‑2 PCR diagnostic platforms.
Hospitals needed fast results to care for critically ill patients and control infection; potential outbreaks in vulnerable remote communities, jails and nursing homes would need to be managed.
Faced with a global shortage of reagents for our usual rapid testing platform, potential was spotted in a new contender, Roche’s cobas Liat analyser.
We put it through its paces and it passed with flying colours delivering results within just 20 minutes.
But how to get 165 Liats in use in a range of settings within just six months?
A crack team of people with diverse skills who hadn’t worked together before were drafted into action.
Soon Liats were up and running in 48 of our laboratories, six rapid testing clinics and five emergency departments, delivering results in real time via our award-winning integrated diagnostic pipeline.
Results from remote rapid testing centres were instantly available to lab teams who confirmed COVID diagnoses and notified public health teams in time to enact containment and other management strategies.
From August 2021 to end of April this year, Liats deployed throughout rural, regional and metropolitan NSW gave over 311,000 results.
They’re easy enough for health staff with no microbiology testing experience to use, and flexible enough to also use for Flu A/B testing without changing ICT systems or providing extra training.
More than 100 of the instruments are still in use, giving 38,000 results a month as the pandemic continues.